| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 292 |
| 1 | CLOPIDOGREL | 291 |
| 2 | ASPIRIN 325 MG | 283 |
| 3 | ASPIRIN 81 MG | 283 |
| 4 | CLOPIDOGREL BISULFATE | 212 |
| 5 | RIVAROXABAN | 149 |
| 6 | APIXABAN | 130 |
| 7 | TACROLIMUS | 111 |
| 8 | WARFARIN | 109 |
| 9 | PREDNISONE | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BIVALIRUDIN | 18 | 0.0181 |
| 1 | THROMBIN HUMAN AND FIBRINOGEN | 5 | 0.0149 |
| 2 | HEPARIN SODIUM AND DEXTROSE | 7 | 0.0097 |
| 3 | PRASUGREL HYDROCHLORIDE | 43 | 0.0042 |
| 4 | ARGATROBAN | 5 | 0.0033 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 25 | 0.0030 |
| 6 | TIROFIBAN | 7 | 0.0024 |
| 7 | CLOPIDOGREL BISULFATE | 212 | 0.0020 |
| 8 | HEPARIN SODIUM | 28 | 0.0020 |
| 9 | APIXABAN | 130 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 380 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 296 |
| 2 | Factor Xa Inhibitor [EPC] | 279 |
| 3 | Corticosteroid [EPC] | 232 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 214 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 104 |
| 6 | Proton Pump Inhibitor [EPC] | 97 |
| 7 | Loop Diuretic [EPC] | 92 |
| 8 | Benzodiazepine [EPC] | 70 |
| 9 | Platinum-based Drug [EPC] | 67 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 1 | 0.0222 |
| 1 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 2 | Anti-coagulant [EPC] | 23 | 0.0062 |
| 3 | Human Blood Coagulation Factor [EPC] | 5 | 0.0061 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 214 | 0.0018 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Factor Xa Inhibitor [EPC] | 279 | 0.0010 |
| 7 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 8 | Antimalarial [EPC] | 9 | 0.0009 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 19 | 0.0009 |